NCT02730130 Study to Assess the Efficacy of Pembrolizumab Plus Radiotherapy in Metastatic Triple Negative Breast Cancer Patients Status COMPLETED Phase PHASE2
NCT02729714 A Pilot Study of Suvorexant for Insomnia in Parkinson Disease Status COMPLETED Phase PHASE4
NCT02728830 A Study of Pembrolizumab on the Tumoral Immunoprofile of Gynecologic Cancers Status COMPLETED Phase EARLY_PHASE1
NCT02728726 Sugammadex vs Placebo to Prevent Residual Neuromuscular Block Status COMPLETED Phase PHASE4
NCT02728089 Study of Ceftolozane/Tazobactam (MK-7625A) in Japanese Participants With Uncomplicated Pyelonephritis and Complicated Urinary Tract Infection (MK-7625A-014) Status COMPLETED Phase PHASE3
NCT02724111 Effect of Neuromuscular Blockade on Operating Conditions and Overall Satisfaction During Spinal Surgery Status COMPLETED Phase PHASE4
NCT02723955 Dose Escalation and Expansion Study of GSK3359609 in Participants With Selected Advanced Solid Tumors (INDUCE-1) Status COMPLETED Phase PHASE1
NCT02720081 Study of MK-1029 in Participants With Persistent Asthma That Cannot Be Controlled With Montelukast (MK-1029-015) Status COMPLETED Phase PHASE2
NCT02720068 Study of Favezelimab (MK-4280) as Monotherapy and in Combination With Pembrolizumab (MK-3475) With or Without Chemotherapy or Lenvatinib (MK-7902) AND Favezelimab/Pembrolizumab (MK-4280A) as Monotherapy in Adults With Advanced Solid Tumors (MK-4280-001) Status COMPLETED Phase PHASE1
NCT02715700 Effects of Doravirine (MK-1439) on Methadone Pharmacokinetics in Methadone-Maintained Participants (MK-1439-045) Status COMPLETED Phase PHASE1
NCT02713529 Safety and Efficacy Study of AMG 820 and Pembrolizumab Combination in Select Advanced Solid Tumor Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT02713373 Cetuximab and Pembrolizumab in Treating Patients With Colorectal Cancer That is Metastatic or Cannot Be Removed by Surgery Status COMPLETED Phase PHASE1/PHASE2
NCT02708641 A Phase II Study of Pembrolizumab as Post-Remission Treatment of Patients ≥ 60 With AML Status COMPLETED Phase PHASE2
NCT02708342 Observational, Retrospective Analysis in HIV-1 Infected Patients. (ORASWIRAL) Status COMPLETED Phase N/A
NCT02705820 Switch Maintenance Pembrolizumab in Patients With NSCLC After First Line Platinum Doublet Chemotherapy Status COMPLETED Phase PHASE2
NCT02702414 Study of Pembrolizumab (MK-3475) as Monotherapy in Participants With Advanced Hepatocellular Carcinoma (MK-3475-224/KEYNOTE-224) Status COMPLETED Phase PHASE2